Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study

BACKGROUND: Gastrointestinal angiodysplasias (GIADs) could be responsible for recurrent bleeding and severe anemia. Somatostatin analogs could reduce transfusion requirements in these patients but no randomized controlled study is available. The main objective of the ANGIOPAS phase II double-blinded...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Therap Adv Gastroenterol
Main Authors: Benamouzig, Robert, Benallaoua, Mourad, Saurin, Jean-Christophe, Boubaya, Marouane, Cellier, Christophe, Laugier, René, Vincent, Magalie, Boustière, Christian, Gincul, Rodica, Samaha, Elia, Grandval, Philippe, Aparicio, Thomas, Airinei, Gheorghe, Bejou, Bakhtiar, Bon, Cyriaque, Raynaud, Jean-Jacques, Levy, Vincent, Sautereau, Denis
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5818089/
https://ncbi.nlm.nih.gov/pubmed/29479375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X18756260
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados